Dr Richard Grose
Richard Grose is a group leader and Reader in Cancer Cell biology at Barts Cancer Institute, where his group focuses on cell signalling both in the context of cancer development/progression and in targeted therapies/resistance. His work uses 3D models to understand cancer cell behaviour in a physiomimetic environment, and most recently has focused on modelling early breast cancer.
Having read Zoology at Bristol, he worked at Pfizer prior to undertaking a PhD in embryonic wound healing with Prof Paul Martin at UCL. During postdoctoral research with Prof Sabine Werner at ETH Zurich and then Prof Clive Dickson at CRUK LRI, he began to work on FGF signalling in cancer, and this has been a major focus of his group at Barts since 2004. The group are interested in how FGFR signalling is hijacked in a range of cancers and, in particular, how it can be targeted in cancer therapy.